{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:04:14Z","timestamp":1787015054907,"version":"build-2736575974"},"reference-count":52,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2012,5,11]],"date-time":"2012-05-11T00:00:00Z","timestamp":1336694400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Basic Clin Pharma Tox"],"published-print":{"date-parts":[[2012,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Biochemical markers of cardiovascular disease, including matrix metalloproteinases (\n                    <jats:styled-content style=\"fixed-case\">MMP<\/jats:styled-content>\n                    s), are altered in women with polycystic ovary syndrome (\n                    <jats:styled-content style=\"fixed-case\">PCOS<\/jats:styled-content>\n                    ), with many of these alterations thought to be due to excess androgen concentrations. Despite oral contraceptives (\n                    <jats:styled-content style=\"fixed-case\">OC<\/jats:styled-content>\n                    s) being the first\u2010line pharmacological treatment in women with\n                    <jats:styled-content style=\"fixed-case\">PCOS<\/jats:styled-content>\n                    and the importance of\n                    <jats:styled-content style=\"fixed-case\">MMP<\/jats:styled-content>\n                    s in many physiological conditions and pathological states, including cardiovascular diseases, no study has yet evaluated whether\n                    <jats:styled-content style=\"fixed-case\">OC<\/jats:styled-content>\n                    s alter plasma concentrations of\n                    <jats:styled-content style=\"fixed-case\">MMP<\/jats:styled-content>\n                    s. We therefore assessed whether treatment with an\n                    <jats:styled-content style=\"fixed-case\">OC<\/jats:styled-content>\n                    containing the anti\u2010androgenic progestogen alters\n                    <jats:styled-content style=\"fixed-case\">MMP<\/jats:styled-content>\n                    profiles in women with\n                    <jats:styled-content style=\"fixed-case\">PCOS<\/jats:styled-content>\n                    . We analysed 20 women with\n                    <jats:styled-content style=\"fixed-case\">PCOS<\/jats:styled-content>\n                    who wanted hormonal contraception (\n                    <jats:styled-content style=\"fixed-case\">OC<\/jats:styled-content>\n                    \u2010\n                    <jats:styled-content style=\"fixed-case\">PCOS<\/jats:styled-content>\n                    group), 20 ovulatory women who required hormonal contraception (\n                    <jats:styled-content style=\"fixed-case\">OC<\/jats:styled-content>\n                    \u2010control group) and 20 ovulatory women who wanted non\u2010hormonal contraception (non\u2010\n                    <jats:styled-content style=\"fixed-case\">OC<\/jats:styled-content>\n                    \u2010control group).\n                    <jats:styled-content style=\"fixed-case\">OC<\/jats:styled-content>\n                    consisted of cyclic use of 2\u00a0mg chlormadinone acetate\/30\u00a0\u03bcg ethinylestradiol for 6\u00a0months. Plasma concentrations of\n                    <jats:styled-content style=\"fixed-case\">MMP<\/jats:styled-content>\n                    \u20102,\n                    <jats:styled-content style=\"fixed-case\">MMP<\/jats:styled-content>\n                    \u20109,\n                    <jats:styled-content style=\"fixed-case\">TIMP<\/jats:styled-content>\n                    \u20101 and\n                    <jats:styled-content style=\"fixed-case\">TIMP<\/jats:styled-content>\n                    \u20102 were measured by gelatin zymography or enzyme\u2010linked immunoassays.\n                    <jats:styled-content style=\"fixed-case\">OC<\/jats:styled-content>\n                    treatment for 6\u00a0months significantly reduced plasma\n                    <jats:styled-content style=\"fixed-case\">MMP<\/jats:styled-content>\n                    \u20102 concentrations in the\n                    <jats:styled-content style=\"fixed-case\">OC<\/jats:styled-content>\n                    \u2010control and\n                    <jats:styled-content style=\"fixed-case\">OC<\/jats:styled-content>\n                    \u2010\n                    <jats:styled-content style=\"fixed-case\">PCOS<\/jats:styled-content>\n                    groups and\n                    <jats:styled-content style=\"fixed-case\">TIMP<\/jats:styled-content>\n                    \u20102 and\n                    <jats:styled-content style=\"fixed-case\">TIMP<\/jats:styled-content>\n                    \u20101 concentrations levels in the\n                    <jats:styled-content style=\"fixed-case\">OC<\/jats:styled-content>\n                    \u2010control group (all\n                    <jats:italic>p<\/jats:italic>\n                    \u00a0&lt;\u00a00.05), but had no effects on\n                    <jats:styled-content style=\"fixed-case\">MMP<\/jats:styled-content>\n                    \u20109 concentrations or on\n                    <jats:styled-content style=\"fixed-case\">MMP<\/jats:styled-content>\n                    \u20102\/\n                    <jats:styled-content style=\"fixed-case\">TIMP<\/jats:styled-content>\n                    \u20102 and\n                    <jats:styled-content style=\"fixed-case\">MMP<\/jats:styled-content>\n                    \u20109\/\n                    <jats:styled-content style=\"fixed-case\">TIMP<\/jats:styled-content>\n                    \u20101 ratios in any group (all\n                    <jats:italic>p<\/jats:italic>\n                    \u00a0&gt;\u00a00.05). These findings indicated that long\u2010term treatment with an\n                    <jats:styled-content style=\"fixed-case\">OC<\/jats:styled-content>\n                    containing chlormadinone acetate plus ethinylestradiol reduced plasma\n                    <jats:styled-content style=\"fixed-case\">MMP<\/jats:styled-content>\n                    \u20102 concentrations in both healthy and\n                    <jats:styled-content style=\"fixed-case\">PCOS<\/jats:styled-content>\n                    women. As the latter have imbalances in circulating matrix\n                    <jats:styled-content style=\"fixed-case\">MMP<\/jats:styled-content>\n                    s, treatment of these women with an\n                    <jats:styled-content style=\"fixed-case\">OC<\/jats:styled-content>\n                    may be beneficial.\n                  <\/jats:p>","DOI":"10.1111\/j.1742-7843.2012.00895.x","type":"journal-article","created":{"date-parts":[[2012,4,18]],"date-time":"2012-04-18T07:15:13Z","timestamp":1334733313000},"page":"211-216","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Oral Contraceptive Containing Chlormadinone Acetate and Ethinylestradiol Reduces Plasma Concentrations of Matrix Metalloproteinase\u20102 in Women with Polycystic Ovary Syndrome"],"prefix":"10.1111","volume":"111","author":[{"given":"Val\u00e9ria A.","family":"Gomes","sequence":"first","affiliation":[{"name":"Department of Pharmacology Faculty of Medical Sciences State University of Campinas  Campinas SP Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina S.","family":"Vieira","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics Faculty of Medicine of Ribeir\u00e3o Preto University of S\u00e3o Paulo  Ribeir\u00e3o Preto SP Brazil"},{"name":"National Institute of Hormones and Women's Health  Ribeir\u00e3o Preto SP Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna L.","family":"Jacob\u2010Ferreira","sequence":"additional","affiliation":[{"name":"Department of Pharmacology Faculty of Medical Sciences State University of Campinas  Campinas SP Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa A.","family":"Belo","sequence":"additional","affiliation":[{"name":"Department of Pharmacology Faculty of Medical Sciences State University of Campinas  Campinas SP Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo M.","family":"Soares","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics Faculty of Medicine of Ribeir\u00e3o Preto University of S\u00e3o Paulo  Ribeir\u00e3o Preto SP Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana\u00edna B.","family":"Fran\u00e7a","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics Faculty of Medicine of Ribeir\u00e3o Preto University of S\u00e3o Paulo  Ribeir\u00e3o Preto SP Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui A.","family":"Ferriani","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics Faculty of Medicine of Ribeir\u00e3o Preto University of S\u00e3o Paulo  Ribeir\u00e3o Preto SP Brazil"},{"name":"National Institute of Hormones and Women's Health  Ribeir\u00e3o Preto SP Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose E.","family":"Tanus\u2010Santos","sequence":"additional","affiliation":[{"name":"Department of Pharmacology Faculty of Medicine of Ribeir\u00e3o Preto University of S\u00e3o Paulo  Ribeir\u00e3o Preto SP Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,5,11]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.2006.01712.x"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-0842"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2009.02.022"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dei100"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-031867"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2008.03506.x"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.20.11.2414"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-032237"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2007.10.011"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1161\/res.90.3.251"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1191\/1358863x03vm504ra"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2362.2003.01187.x"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.31.1.40"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000151373.33830.41"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000058700.41738.12"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1161\/hh1501.094396"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1159\/000087197"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.carpath.2007.12.012"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1080\/09513590802056995"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-07-0822"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-0648"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-011-0793-6"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deh098"},{"key":"e_1_2_6_25_1","volume-title":"Medical Eligibility Criteria for Contraceptive Use","author":"Organization WH","year":"2009"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/18.6.499"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(16)45254-4"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00280883"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2005.02.010"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ab.2005.04.038"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2006.10.007"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61345-2"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-2279"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dem324"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmi005"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1177\/1933719110371515"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-010-0573-y"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2008.06.096"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2010.00678.x"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-011-0623-0"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.fjc.0000196241.96759.71"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1210\/en.2002-0157"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1745-7262.2007.00226.x"},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1095\/biolreprod64.1.157"},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000187016.06549.96"},{"key":"e_1_2_6_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.matbio.2009.11.005"},{"key":"e_1_2_6_47_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-7843.2010.00656.x"},{"key":"e_1_2_6_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2010.02.005"},{"key":"e_1_2_6_49_1","doi-asserted-by":"publisher","DOI":"10.1038\/jhh.2011.8"},{"key":"e_1_2_6_50_1","doi-asserted-by":"publisher","DOI":"10.1038\/ijo.2011.169"},{"key":"e_1_2_6_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2009.02.013"},{"key":"e_1_2_6_52_1","doi-asserted-by":"publisher","DOI":"10.1159\/000336108"},{"key":"e_1_2_6_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexmp.2012.01.008"}],"container-title":["Basic &amp; Clinical Pharmacology &amp; Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1742-7843.2012.00895.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1742-7843.2012.00895.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T17:22:07Z","timestamp":1698772927000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1742-7843.2012.00895.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,11]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["10.1111\/j.1742-7843.2012.00895.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1742-7843.2012.00895.x","archive":["Portico"],"relation":{},"ISSN":["1742-7835","1742-7843"],"issn-type":[{"value":"1742-7835","type":"print"},{"value":"1742-7843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,11]]},"assertion":[{"value":"2012-03-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2012-04-10","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2012-05-11","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}